Leonard Mazur
Chief Executive Officer,
Citius Pharmaceuticals
United States
Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with
notable success in founding and building multiple healthcare companies and creating
value and returns for investors throughout his five-decade career. Mr. Mazur was the co-
founder and Chairman of Leonard-Meron Biosciences prior to its merger with Citius in
March 2016. Previously, he was the co-founder and vice chairman of Akrimax
Pharmaceuticals, which specialized in cardiovascular and general pharmaceutical
products. Earlier, he co-founded and served as chief operating officer of Triax
Pharmaceuticals, a specialty pharmaceutical producer of prescription dermatological
drugs, and he was the founder and CEO of Genesis Pharmaceuticals, a dermatological
products company. Mr. Mazur has extensive sales, marketing, and business
development experience from previous tenures at Medicis Pharmaceutical Corporation,
ICN Pharmaceuticals, Knoll Pharma (a division of BASF), and Cooper Laboratories. Mr.
Mazur served in the U.S. Marine Corps Reserve and earned an an MBA from Temple
University’s Fox School of Business. Mr. Mazur is a recipient of the Ellis Island Medal of
Honor presented annually to those who immigrated to the United States during the Ellis
Island era and have shown an outstanding commitment to serving the United States
either professionally, culturally, or civically.
Sessions
-
10-Feb-2025Citius Pharmaceuticals
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}